Leerie T. Jenkins Jr. Reelected to Serve on Blue Cross and Blue Shield of Florida Board of Directors

JACKSONVILLE, Fla., Sept. 9 Announced at today's annualpolicyholders' meeting, Leerie T. Jenkins, Jr. was reelected to serve athree-year term on Blue Cross and Blue Shield of Florida's (BCBSF) Board ofDirectors. Jenkins, an Orange Park resident, is chairman and chief executiveofficer of Reynolds, Smith and Hills, Inc. (RSH).

(Logo: http://www.newscom.com/cgi-bin/prnh/20000427/BLUELOGOA )

During his 36 years with RSH, Jenkins has served in various senior levelmanagement positions including in the planning services division and aspresident and CEO of the company's North Carolina operations.

Jenkins is also a member of the Florida Council of 100 and the Gator BowlAssociation, and serves on the boards of the Florida Chamber of Commerce andthe Jacksonville Chamber of Commerce. He previously served as chair of theFlorida Chamber of Commerce, the Jacksonville Chamber of Commerce andLeadership Florida.

In addition to Jenkins, John B. Ramil and Robert I. Lufrano, M.D. werereelected for three-year terms at today's policyholders' meeting. BCBSF alsoannounced today the retirement of board member DuBose Ausley after 26 years ofdedicated service.

Blue Cross and Blue Shield of Florida is a leader in Florida's healthindustry. BCBSF and its subsidiaries serve more than 8.8 million people. Since1944, the company has been dedicated to meeting the diverse needs of all thoseit serves by offering an array of choices. BCBSF is a not-for-profit,policyholder-owned, tax-paying mutual company. Headquartered in Jacksonville,Fla., BCBSF is an independent licensee of the Blue Cross and Blue ShieldAssociation, an association of independent Blue Cross and Blue Shieldcompanies. For more information concerning BCBSF, please see its Web site atwww.bcbsfl.com .

SOURCE Blue Cross and Blue Shield of Florida

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...